关于调节动脉样硬化中的编程细胞死亡的质脱乙酶的研究进展
Gang Zhou1,2,3, Yanfang Liu1,2,3, Hui Wu4,5,6
1Institute of Cardiovascular Disease, China Three Gorges University, Yichang, 443003, China.
Journal of cardiovascular translational research
|October 11, 2023
概括
基因组脱乙酶 (HDACs) 调节细胞死亡程序的途径,如细胞灭绝和自,这对动脉样硬化发展至关重要. 了解HDAC为这种心血管疾病提供了新的治疗点.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
- 心血管疾病研究研究
背景情况:
- 基因组脱乙酶 (HDACs) 是一种表观遗传酶,影响基因转录和染色质结构.
- 在动脉样硬化的病理生理学中,HDACs起着重要的作用.
- 编程细胞死亡,包括亡,自和编程亡,都与动脉样硬化的进展有关.
研究的目的:
- 提供HDACs和编程细胞死亡机制的概述.
- 详细阐述HDACs在调节动脉样硬化中的亡,自和编程性亡中的特定作用.
- 为抗动脉样硬化的新型治疗策略提供理论基础.
主要方法:
- 审查关于HDACs,编程细胞死亡和动脉样硬化现有的文献.
- 对HDACs调节亡,自和编程亡的分子机制的分析.
- 综合现有证据,突出针对HDACs的治疗潜力.
主要成果:
- HDACs是与动脉样硬化相关的多种编程细胞死亡途径的关键调节者.
- 在动脉样硬化疾病的背景下,特定的HDACs会影响亡,自和编程亡.
- 准HDACs是治疗动脉样硬化的有希望的途径.
结论:
- 在动脉样硬化背后的编程细胞死亡过程中,HDACs是关键的调解者.
- 对HDAC介导的细胞死亡机制的进一步研究可以为开发向治疗提供信息.
- 调节HDAC活性具有预防和治疗动脉样硬化的潜力.
相关概念视频
Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Inflammation
53.7K
Overview
53.7K
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Overview of Cell Death
7.3K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.3K
Spreading of Chromatin Modifications
8.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.3K
Apoptosis
11.5K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.5K


